Evidence map›Paper›PMID 18003729›Full record

ArticleJournal of virology2008

The spike glycoprotein of murine coronavirus MHV-JHM mediates receptor-independent infection and spread in the central nervous systems of Ceacam1a-/- Mice.

Tanya A Miura, Emily A Travanty, Lauren Oko, Helle Bielefeldt-Ohmann, Susan R Weiss, Nicole Beauchemin, Kathryn V Holmes

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 63 citations in OpenAlex.

  1. Clade C MERS-CoV camel strains vary in protease utilization during viral entry.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Tanya A MiuraDepartment of Microbiology MS 8333, University of Colorado Health Sciences Center, 12800 E. 19th Ave., P.O. Box 6511, Aurora, CO 80045, USA.
Emily A Travanty
Lauren Oko
Helle Bielefeldt-Ohmann
Susan R Weiss
Nicole Beauchemin
Kathryn V Holmes
University of Colorado Anschutz Medical Campus · USColorado State University · USMcGill University · CAUniversity of Colorado Health · USUniversity of Pennsylvania · US

Funding

MOLECULAR GENETICS OF THE RECEPTOR FOR MVHR01AI025231 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLMES, KATHRYN V · 1988 to 2007
$3.5M
Molecular Biology of Coronavirus Induced DemyelinationR01AI060021 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R · 2003 to 2013
$2.7M
NIAID NIH HHS AI25231NIAID NIH HHS AI60021NIAID NIH HHS N01 AI060021NIAID NIH HHS R01 AI025231
6 · The paper itself

Abstract

The MHV-JHM strain of the murine coronavirus mouse hepatitis virus is much more neurovirulent than the MHV-A59 strain, although both strains use murine CEACAM1a (mCEACAM1a) as the receptor to infect murine cells. We previously showed that Ceacam1a(-/-) mice are completely resistant to MHV-A59 infection (E. Hemmila et al., J. Virol. 78:10156-10165, 2004). In vitro, MHV-JHM, but not MHV-A59, can spread from infected murine cells to cells that lack mCEACAM1a, a phenomenon called receptor-independent spread. To determine whether MHV-JHM could infect and spread in the brain independent of mCEACAM1a, we inoculated Ceacam1a(-/-) mice. Although Ceacam1a(-/-) mice were completely resistant to i.c. inoculation with 10(6) PFU of recombinant wild-type MHV-A59 (RA59) virus, these mice were killed by recombinant MHV-JHM (RJHM) and a chimeric virus containing the spike of MHV-JHM in the MHV-A59 genome (SJHM/RA59). Immunohistochemistry showed that RJHM and SJHM/RA59 infected all neural cell types and induced severe microgliosis in both Ceacam1a(-/-) and wild-type mice. For RJHM, the 50% lethal dose (LD(50)) is <10(1.3) in wild-type mice and 10(3.1) in Ceacam1a(-/-) mice. For SJHM/RA59, the LD(50) is <10(1.3) in wild-type mice and 10(3.6) in Ceacam1a(-/-) mice. This study shows that infection and spread of MHV-JHM in the brain are dependent upon the viral spike glycoprotein. RJHM can initiate infection in the brains of Ceacam1a(-/-) mice, but expression of mCEACAM1a increases susceptibility to infection. The spread of infection in the brain is mCEACAM1a independent. Thus, the ability of the MHV-JHM spike to mediate mCEACAM1a-independent spread in the brain is likely an important factor in the severe neurovirulence of MHV-JHM in wild-type mice.

Indexed as

Virus InternalizationAnimalsBrainCarcinoembryonic AntigenCentral Nervous SystemCoronavirus InfectionsGene DeletionLethal Dose 50Membrane GlycoproteinsMiceMice, Inbred C57BLMice, KnockoutMurine hepatitis virusSpike Glycoprotein, CoronavirusSurvival AnalysisViral Envelope ProteinsCarcinoembryonic AntigenCeacam1 protein, mouseMembrane GlycoproteinsSpike Glycoprotein, CoronavirusViral Envelope ProteinsVirulence Factors

Identifiers

PMID18003729
PMCPMC2224565
OpenAlexW2163882935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.